CION Ameerpet
CA-125 is the most misread blood test in gynaecology. A raised result usually is not cancer, and a normal result does not rule it out — which is why it is never interpreted on its own, and why a number handed over without context causes so much unnecessary fear.
CA-125 is a protein, and the crucial thing to understand is where it comes from. It is produced by cells derived from the coelomic epithelium — a tissue type that lines not just the ovary but the peritoneum lining your abdominal cavity, the pleura around your lungs and the pericardium around your heart.
That single fact explains almost everything confusing about this test. Anything that irritates or inflames those surfaces can raise CA-125: endometriosis, fibroids, pelvic infection, liver disease, heart failure, recent surgery, and even the ordinary inflammation of a menstrual period. None of these has anything to do with cancer, and all of them produce raised numbers.
It also explains the reverse problem. A small early ovarian cancer confined to one ovary may produce very little CA-125 at all, because it has not yet involved enough of that tissue to shift the blood level. So a normal result is genuinely reassuring in some contexts and close to meaningless in others. The number alone answers almost nothing — which is why it should never be handed over without the scan, your age and your menopausal status alongside it.
It comes from the peritoneum, pleura and pericardium too. That is why so many non-ovarian conditions raise it.
Endometriosis, fibroids, infection, liver disease and even a period all raise it, entirely benignly.
A small early ovarian cancer may not shift the level at all. A normal result proves considerably less than people assume.
The commonly quoted upper limit of 35 U/mL is not a line between healthy and diseased — it is a statistical cut-off, chosen because roughly 99% of healthy women fall below it. That means around one in a hundred healthy women is above it for no reason at all. It also means the cut-off performs quite differently before and after the menopause: in premenopausal women, endometriosis, fibroids and menstruation push a substantial number above 35 entirely benignly, while after the menopause those causes are largely absent and the same number carries more weight. A single threshold applied to everyone is the source of most CA-125 anxiety. Source: NCCN Ovarian Cancer guidelines; standard laboratory reference practice.
This list is long, common and the reason a raised result on its own means so little. Most women with an elevated CA-125 have one of these.
Endometriosis raises CA-125 routinely, and endometriomas raise it more than most other benign causes. Values well above the cut-off are entirely expected in a woman with significant endometriosis, and they say nothing about cancer.
This is the single most frequent source of avoidable alarm in premenopausal women. A raised CA-125 alongside a classic ground-glass endometrioma on ultrasound is an expected finding, not a warning sign. See endometrioma.
CA-125 fluctuates across the cycle and is typically highest during menstruation. A test taken during a period can return a raised value that would have been normal a week later, which is a genuinely common cause of unnecessary repeat testing and worry.
Where a CA-125 is being measured in a premenopausal woman, timing it away from menstruation gives a more interpretable result. If yours was taken during a period and came back raised, that is worth mentioning.
Uterine fibroids, adenomyosis, ovarian cysts of all types and pelvic inflammatory disease can all raise CA-125. So can pregnancy, particularly in the first trimester, which is why the test is essentially uninterpretable during pregnancy.
These are extremely common conditions. The frequency with which they coexist with an incidental raised CA-125 is precisely why the ultrasound appearance carries far more weight than the blood test.
Any condition that inflames or stretches the peritoneum raises CA-125, and fluid in the abdomen does exactly that. Cirrhosis and other chronic liver disease, heart failure and kidney disease can all produce substantially elevated values.
This matters because ascites is also how advanced ovarian cancer presents — so a raised CA-125 with ascites is genuinely ambiguous and needs imaging and often fluid analysis to sort out, not more blood tests. See ascites.
Pelvic inflammatory disease, appendicitis, diverticulitis, pneumonia and pleural disease can all raise CA-125, because the pleura produces it too. Recent abdominal or pelvic surgery raises it for a period afterwards through simple surgical inflammation.
Abdominal tuberculosis deserves specific mention in this region: it can produce pelvic masses, ascites and a substantially raised CA-125 that together closely mimic ovarian malignancy, and it is entirely treatable. A good work-up considers it rather than assuming.
CA-125 is not specific to ovarian cancer even among malignancies. It can be raised in endometrial, fallopian tube, peritoneal, pancreatic, lung, breast and colorectal cancer, and in lymphoma — reflecting the same coelomic epithelial origin and peritoneal or pleural involvement.
This is one reason a substantially raised CA-125 with no ovarian abnormality on scan prompts a broader look rather than repeated pelvic imaging. The marker is telling you something is irritating those surfaces; it is not telling you where.
The same number carries entirely different weight depending on who you are and what the scan showed.
| Situation | How the result is read | Usual next step |
|---|---|---|
| Premenopausal, normal scan, mildly raised | Very often benign — endometriosis, fibroids, timing in cycle. | Usually reassurance; repeat away from a period if there is doubt. |
| Premenopausal, endometrioma on scan, raised | Expected. Endometriosis raises CA-125 routinely. | No escalation warranted on the number alone. |
| Post-menopausal, normal scan, mildly raised | Carries more weight; benign causes are less common. | Repeat and consider further imaging; combined risk assessment. |
| Post-menopausal, complex mass, raised | The combination that matters most. | Risk of Malignancy Index and referral to a specialist service. |
| Normal CA-125, concerning scan | Does not exclude anything. The scan leads. | Proceed on the imaging — MRI or specialist referral. |
| Substantially raised, no ovarian abnormality | Points beyond the ovary — liver, bowel, chest, TB. | Broader work-up rather than repeated pelvic scans. |
| Any result in pregnancy | Essentially uninterpretable. Rises physiologically. | The test should generally not have been done. |
*A single CA-125 is a snapshot. Trend over time is often more informative than any one value, particularly for monitoring after a diagnosis. See CA-125 monitoring.
None of these means cancer. Each is a reason for proper assessment rather than reassurance on the number alone.
The benign causes that inflate CA-125 in younger women are largely absent after the menopause, so the same value means more.
Solid components, papillary projections or internal blood flow on the scan, together with a raised marker.
Free fluid in the abdomen alongside a raised CA-125 warrants prompt imaging rather than a repeat blood test.
A value climbing over successive tests is more meaningful than a single elevated snapshot.
Persistent bloating, early satiety, pelvic pain or urinary urgency alongside a raised result.
A substantially elevated value with a normal pelvis warrants looking beyond the ovary rather than rescanning it.
Equally important: a normal CA-125 with a concerning scan or persistent symptoms should not reassure anyone. The imaging and the symptoms lead.
CA-125 handed over without the scan, your age and your menopausal status alongside it is close to uninterpretable — and it causes weeks of avoidable fear.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them - together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
No referral needed and no cost for the first consultation. Bring the result and any scan report — together they usually settle the question.
A great deal of CA-125 distress originates before the result — in the decision to order it. The test is quick, cheap and easy to add to a panel, and it is frequently requested in situations where it cannot answer anything useful.
It is not a screening test. Large randomised trials have not shown that CA-125 screening reduces ovarian cancer deaths, in the general population or in high-risk women. Ordering it in a woman with no symptoms and no pelvic abnormality reliably produces a proportion of raised results that lead to further imaging, weeks of severe anxiety, and occasionally surgery on a healthy ovary that finds nothing.
Where it genuinely adds information is alongside a pelvic ultrasound in a woman who has symptoms or a known ovarian abnormality, interpreted with her age and menopausal status. And it is genuinely valuable for monitoring once a diagnosis is established, where the trend over time tracks response to treatment. Those are the two proper uses. A CA-125 as a general check is not one of them.
Trials have not shown it reduces deaths. Ordered as a general check, it produces more anxiety than information.
In a woman with symptoms or a known ovarian abnormality, read with her age and menopausal status.
Once a diagnosis is established, the trend over time tracks treatment response well.
False positives lead to imaging, anxiety and occasionally surgery on a healthy ovary.
The commonest way this test causes harm is not a wrong result — it is a right result handed over with no context. A number on a report, a note saying it is above the reference range, and no appointment for three weeks. What follows is entirely predictable and completely avoidable.
Your first consultation at CION is free and runs to about 45 minutes. Bring the CA-125 result and any scan report, because they only mean anything together. In a large share of cases the useful outcome is straightforward: explaining which benign cause most likely accounts for your value, why the scan appearance carries more weight, and what — if anything — needs doing next.
We will also say when a test should not have been ordered. A CA-125 in a 30-year-old with cyclical bloating and a normal examination answers nothing and worries everyone, and adding more blood tests to an uninterpretable one does not help. Where the combined picture does warrant it, care moves to a gynaecologic-oncology pathway with a tumour-board discussion; chemotherapy and maintenance treatment are delivered in-house across 35+ centres, while surgery is coordinated with specialist partner centres and may be billed there.
Free and unhurried. Long enough to read the number alongside the scan rather than in isolation.
CA-125 and the scan report only mean anything together, along with your age and menopausal status.
Decisions for healing, not billing. We will say plainly when a test should not have been ordered.
Assessment, follow-up and any subsequent care near where you live across Telangana and Andhra Pradesh.
Almost certainly not, particularly if you are premenopausal. CA-125 is produced not only by ovarian tissue but by the peritoneum, pleura and pericardium, so anything that irritates or inflames those surfaces raises it — endometriosis, fibroids, ovarian cysts, pelvic infection, liver disease, heart failure, recent surgery, and even an ordinary menstrual period. Most women with a raised CA-125 have one of these. What matters far more than the number is what your pelvic ultrasound shows, alongside your age and menopausal status. The blood test alone answers very little.
The commonly quoted upper limit is 35 U/mL, but it is important to understand what that figure is. It is a statistical cut-off chosen because roughly 99 per cent of healthy women fall below it — which means about one in a hundred healthy women is above it for no reason at all. It also performs quite differently before and after the menopause: in premenopausal women a substantial number exceed it entirely benignly because of endometriosis, fibroids or cycle timing, while after the menopause those causes are largely absent and the same value carries more weight.
No, and this is the more dangerous half of the misunderstanding. A small early ovarian cancer confined to one ovary may produce very little CA-125, because it has not involved enough tissue to shift the blood level. Certain subtypes, including mucinous ovarian cancer, characteristically produce little CA-125 at any stage. So a normal result should never be used to dismiss a concerning scan or persistent symptoms. If your imaging is worrying or you have persistent bloating, early satiety, pelvic pain or new urinary urgency, those lead — not the blood test.
Because endometriosis raises CA-125 routinely, and endometriomas raise it more than most other benign causes. Values well above the cut-off are entirely expected in a woman with significant endometriosis and say nothing about cancer. This is the single most frequent source of avoidable alarm in premenopausal women. A raised CA-125 alongside a classic ground-glass endometrioma on ultrasound is an expected finding rather than a warning sign, and it is exactly why the test should never be read in isolation from the imaging.
No. CA-125 is not a screening test, and large randomised trials have not shown that screening with it reduces ovarian cancer deaths — in the general population or in high-risk women including BRCA carriers. Ordered as a general check in a woman with no symptoms and a normal pelvis, it reliably produces a proportion of raised results that lead to further imaging, weeks of severe anxiety and occasionally surgery on a healthy ovary that finds nothing. The harms of that are certain; the benefit has not been demonstrated.
It usually means the source is not the ovary, and the right response is a broader look rather than repeated pelvic scans. CA-125 rises with irritation of the peritoneum, pleura and pericardium, so liver disease, heart failure, pleural disease, pneumonia, bowel conditions and recent surgery can all be responsible. In this region abdominal tuberculosis deserves specific mention, since it can produce ascites and a substantially raised CA-125 that closely mimics malignancy and is entirely treatable. Non-ovarian cancers also raise it. The marker is telling you something is irritating those surfaces, not where.
It depends entirely on why it was measured. For a mildly raised result in a premenopausal woman with a normal scan, a single repeat timed away from menstruation is often all that is needed, and frequently even that is unnecessary. Where it forms part of assessing a known ovarian mass, it is interpreted once alongside the imaging rather than tracked. Where a diagnosis has been established, serial monitoring is genuinely valuable because the trend over time reflects response to treatment far better than any single value does.
The first consultation is free and runs to about 45 minutes — bring both the CA-125 result and any scan report, since they only mean anything together. For most women the useful outcome is explaining which benign cause most likely accounts for the value and why the imaging carries more weight. We will also say plainly when a test should not have been ordered. Where the combined picture does warrant it, CION delivers medical oncology in-house across more than 35 centres; surgery is coordinated with specialist partner centres and may be billed there.